Lithium 4,6-dichloropyridazine-3-carboxylate is a chemical compound that serves as a pharmaceutical intermediate. It is specifically used in the manufacturing process of deucravacitinib.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2245238-80-4
4,6-Dichloro-pyridazine-3-carboxylic acid lithium salt monohydrate
pharmaceutical intermediate
Methyl 4,6-dichloropyridazine-3-carboxylate
pharmaceutical intermediate
6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylic acid
pharmaceutical intermediate
(2-Amino-5-nitrophenyl)(2-chlorophenyl)methanone Phthalimido
pharmaceutical intermediate
(2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methanol hydrochloride
pharmaceutical intermediate
4-Amino-3-fluoropyridine
pharmaceutical intermediate
Py-MAA-Val-Cit-PAB-MMAE
pharmaceutical intermediate
4,6-dichloropyridazine-3-carboxylic acid
pharmaceutical intermediate
lithium 4,6-dichloropyridazine-3-carboxylate
DAHURLFXBYFSFD-UHFFFAOYSA-M
[Li+].C1=C(C(=NN=C1Cl)C(=O)[O-])Cl
—